In a previous work, we demonstrated the antiviral activity of the antipsychotic drug lurasidone against both SARS-CoV-2 and HCoV-OC43. In this study, our investigations on the mechanism of action of ...

In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug ...

even though its putative mechanism of action, blockade of 5HT2a and D2 receptors, has been replicated by all of the new generation of antipsychotics. Although all of these medications have been ...

Management of adverse events is a major concern of clinicians who use antipsychotic drugs. The incidence of motor side effects is dose dependent. Atypical antipsychotic drugs are less likely to ...

On 26 September 2024, Cobenfy (KarXT) gained US Food and Drug Administration (FDA) approval as the first novel class of antipsychotics ... Cobenfy’s entry into the market highlights the established ...

On 26 September 2024, Cobenfy (KarXT) gained US Food and Drug Administration (FDA ... and its novel mode of action (MoA) could spark further interest in the development of non-dopaminergic ...

Researchers from the University of California, San Diego, have identified a shared mechanism in the ... how do drugs with distinct mechanisms of action produce similar cognitive impairments?

No clear differences in beneficial outcomes are observed between various antipsychotic drugs ... The average SMDs for each group of medications, grouped by mechanism, were 0.21 in adrenergic ...

Summary: A study of 500,000 Canadian nursing home residents found antipsychotic medications significantly worsened behaviors in patients, with nearly 68% experiencing increased issues. Antipsychotics ...

antipsychotics, stimulants, and mood stabilizers. Notable psychotropic medications include Adderall, Xanax, and Ritalin, among others. If you believe you or a loved one may benefit from the use of ...